Ilika plc Contracted Revenue Grows – AGM Statement

Ilika plc

Ilika Plc (LON:IKA), a pioneer in solid-state battery technology and materials innovation, will hold its Annual General Meeting at 2pm today at the offices of Eversheds LLP, One Wood Street, London, EC2V 7WS. Ahead of the formal proceedings Graeme Purdy, Chief Executive of Ilika, will provide the following update to shareholders:

“We are pleased to report that the first quarter of the year has traded in-line with the Board’s expectations and contracted revenue to date for our current financial year has grown to ÂŁ2.0m.

“Since the announcement of our final results in July, the Company has made good progress towards the goals set out in the StereaxTM development roadmap. Our marketing activities have resulted in an increase in the number of customer disclosure agreements to around 50, including those covering the transfer of StereaxTM products for evaluation, bringing the Company ever closer to licensing agreements.

“The Board remains focused on the development and licensing of Ilika’s solid-state battery technology, investing in the StereaxTM roadmap, finalising manufacturing partnerships and ultimately securing licensing agreements for our StereaxTM technology.”

Ilika plc presentation

After the formal business of the AGM has come to an end, Graeme Purdy, will provide a short presentation to investors with an overview of progress and strategy. No new material will be disclosed in the presentation and it will be made available on the website today.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately ÂŁ1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search